A serum protein-based algorithm for the detection of Alzheimer disease

scientific article

A serum protein-based algorithm for the detection of Alzheimer disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHNEUROL.2010.215
P932PMC publication ID3069805
P698PubMed publication ID20837851
P5875ResearchGate publication ID46255816

P50authorRamon Diaz-ArrastiaQ37370205
Sid O'BryantQ40018183
P2093author name stringGuanghua Xiao
Robert Barber
Rachelle Doody
Joan Reisch
Perrie Adams
Steven Waring
Texas Alzheimer's Research Consortium
Thomas Fairchild
P2860cites workSignificance analysis of microarrays applied to the ionizing radiation responseQ24606608
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-valuesQ30955425
The role of biomarkers in clinical trials for Alzheimer diseaseQ31032781
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteinsQ44917427
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.Q51762261
P433issue9
P921main subjectAlzheimer's diseaseQ11081
P304page(s)1077-1081
P577publication date2010-09-01
P1433published inArchives of NeurologyQ15766672
P1476titleA serum protein-based algorithm for the detection of Alzheimer disease
P478volume67

Reverse relations

cites work (P2860)
Q51760901A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
Q90616563A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use
Q91973479A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Q64943218A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.
Q37085325A blood screening test for Alzheimer's disease
Q35203409A blood-based algorithm for the detection of Alzheimer's disease
Q34341870A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study
Q28741766A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI
Q34851404A depressive endophenotype of mild cognitive impairment and Alzheimer's disease
Q48176222A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study.
Q37564505A double-blind, randomized clinical trial of dietary supplementation on cognitive and immune functioning in healthy older adults
Q35106556A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients
Q64085064A proteomic signature for dementia with Lewy bodies
Q53331705Alzheimer disease: blood-based biomarkers in AD--a silver lining on the horizon.
Q36966044Alzheimer's disease: are blood and brain markers related? A systematic review
Q36517459An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
Q38037149Analytical aspects of molecular Alzheimer's disease biomarkers
Q90415776Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine
Q37248571Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans
Q38592041Biomarkers in Sporadic and Familial Alzheimer's Disease
Q36716970Biomarkers of Alzheimer's disease among Mexican Americans.
Q34442605Biomarkers of Alzheimer's disease: from central nervous system to periphery?
Q36818214Biomarkers of basic activities of daily living in Alzheimer's disease.
Q49165122Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus
Q26774743Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Q60950950Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese
Q64108130Blood-based molecular biomarkers for Alzheimer's disease
Q37881948Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential
Q47378944Blood-based protein biomarkers for diagnosis of Alzheimer disease
Q35857246Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?
Q47587631Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Q36472899Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease
Q33603286Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
Q24289443Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges
Q42683481Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
Q34394080Developing novel blood-based biomarkers for Alzheimer's disease
Q35106599Development and validation of risk index for cognitive decline using blood-derived markers
Q47142477Diagnosis of Alzheimer's disease in Brazil: Supplementary exams.
Q33867548Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease
Q47883557Early diagnosis of Alzheimer's disease using infrared spectroscopy of isolated blood samples followed by multivariate analyses.
Q88341051Ethnoracial differences in brain structure change and cognitive change
Q30996727Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
Q50999408Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
Q58563809Factor structure and measurement invariance of a neuropsychological test battery designed for assessment of cognitive functioning in older Mexican Americans
Q37431174Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI.
Q24289435Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
Q36630566How predictive of dementia are peripheral inflammatory markers in the elderly?
Q56989667Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net
Q34875967Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel
Q39211852Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers
Q50553594Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
Q35099780Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease
Q35844155Metabolome in progression to Alzheimer's disease
Q37325470Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease
Q35497573Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.
Q40457858Molecular markers of amnestic mild cognitive impairment among Mexican Americans.
Q36926716Molecular markers of neuropsychological functioning and Alzheimer's disease
Q35456265Molecular neuropsychology: creation of test-specific blood biomarker algorithms
Q36695912Multiplex assessment of a panel of 16 serum molecules for the differential diagnosis of Alzheimer's disease
Q51408793Multiplexing and multivariate analysis in neurodegeneration.
Q36836566Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Q38093255Novel biomarkers for bipolar disorder
Q34449460Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease
Q35671802Perioperative cognitive decline in the aging population
Q90568291Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
Q39620255PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease
Q34305083Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals
Q34427001Plasma based markers of [11C] PiB-PET brain amyloid burden
Q36932748Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease
Q38037157Plasma biomarkers for Alzheimer's disease: much needed but tough to find
Q36767124Plasma proteomics for the identification of Alzheimer disease
Q36888445Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype
Q64069554Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
Q31063014Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Q96110135Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
Q95269986Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
Q28552035Random Forests Are Able to Identify Differences in Clotting Dynamics from Kinetic Models of Thrombin Generation
Q48145375Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment
Q31110973Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI
Q37079726Risk factors for mild cognitive impairment among Mexican Americans
Q50864602Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients.
Q47822179Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Q41903809Serum granulocyte colony-stimulating factor and Alzheimer's disease
Q37342809Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.
Q64122896Shared biological pathways for frailty and cognitive impairment: A systematic review
Q37642461Single-subject anxiety treatment outcome prediction using functional neuroimaging
Q59811719Systematic Analysis and Biomarker Study for Alzheimer's Disease
Q41661052Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease
Q35082697Teaming up for biomarker future. Many problems still hinder the use of biomarkers in clinical practice, but new public-private partnerships could improve the situation
Q47391588Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers
Q98292287The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology
Q37725833The Hachinski ischemic scale and cognition: the influence of ethnicity.
Q36165011The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations
Q38592265The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease
Q35446931The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer
Q90973905The impact of comorbid depression-diabetes on proteomic outcomes among community-dwelling Mexican Americans with mild cognitive impairment
Q53446502Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.
Q35456060Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues

Search more.